The room fell silent for a few seconds. Shen Bing's remark sounded as though it was aimed only at Korea, but everyone understood the implication: countries with close ties to Huaxia would receive preferential treatment. Those on bad terms with it could forget about that.
Was this discrimination? Perhaps, but Shen Bing did not care anyway.
The corners of Shen Bing's mouth lifted slightly as he continued, "My journalist friend from Korea, rather than worrying about whether Cancer Cure No. 1 will receive preferential pricing in your country, you should consider when our product will be able to enter your country at all. Because... our production capacity really is limited. At present, the medicine we produce each day can treat around ten thousand people at most. Only once we expand production further will we be able to meet the needs of more countries and ultimately solve the global cancer problem."
Shen Bing had already said this earlier. They would have to wait roughly a month before treatment of cancer patients abroad could gradually begin, so no one was surprised.
Some reporters, however, looked rather unhappy. From what Shen Bing was saying, it seemed Phantom Immortal Technology would also be opening up to other countries in stages.
The reporters from countries whose relations with Huaxia were not particularly good were especially anxious.
"Mr. Shen, I'm Klaus from CNN. Could the United States be included among the first countries to introduce Cancer Cure No. 1?"
Shen Bing looked at him seriously. "Mr. Klaus, I think you've forgotten one thing. Not long ago, I said that unless your president abolishes the discriminatory tariffs on products covered by our company's business, none of our products will be exported to the United States. In other words, the United States is currently on our company's blacklist.